Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lenalidomide Plus Dexamethasone as FIRST-Line Therapy in Transplant-Ineligible Patients With Multiple Myeloma: Final Results of the Prospective, Non-Interventional Study FIRST-NIS and Comparison With the FIRST Pivotal Phase III Clinical Trial.

Cancer medicine·2026
Same author

Changes in survival of >3800 patients with metastatic colorectal cancer in Germany: results from a 16-year prospective longitudinal real-world data analysis.

ESMO real world data and digital oncology·2026
Same author

[Sustainable development and eco-design of ophthalmology care: review of the literature].

Journal francais d'ophtalmologie·2025
Same author

[Innovative use of lyophilized umbilical cord amniotic membrane in the treatment of Mooren's Pseudo-ulcer].

Journal francais d'ophtalmologie·2025
Same author

[Cataract surgery training in France: Analysis of the results of the European Board of Ophthalmology survey in the French cohort].

Journal francais d'ophtalmologie·2024
Same author

How do patients define a good ophthalmologist? A survey from an academic medical center in France.

Journal francais d'ophtalmologie·2024
Same journal

Silent threat to sight after bariatric surgery: Vision loss from vitamin A deficiency.

Journal francais d'ophtalmologie·2026
Same journal

Persistent subretinal fluid and subretinal precipitates following pneumatic retinopexy.

Journal francais d'ophtalmologie·2026
Same journal

Real-time documentation of acute pre-retinal hemorrhage in central retinal vein occlusion.

Journal francais d'ophtalmologie·2026
Same journal

Incidental detection of benign lobular inner nuclear layer proliferations (BLIPs) in a young adult.

Journal francais d'ophtalmologie·2026
Same journal

Combined autonomic and cranial neuropathy following radiofrequency ablation for trigeminal neuralgia.

Journal francais d'ophtalmologie·2026
Same journal

[Point-of-care biomarkers of ocular surface disease: Current approaches and future perspectives].

Journal francais d'ophtalmologie·2026
See all related articles

Related Experiment Video

Updated: Jun 2, 2026

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients
05:26

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients

Published on: March 1, 2024

[Fungal keratitis].

T Bourcier1, A Sauer, V Letscher-Bru

  • 1Service d'ophtalmologie, pôle SMOH, nouvel hôpital civil, hôpitaux universitaires et université de Strasbourg, 67000 Strasbourg, France. tristan.bourcier@chru-strasbourg.fr

Journal Francais D'Ophtalmologie
|May 7, 2011
PubMed
Summary
This summary is machine-generated.

Fungal keratitis, a severe eye infection, often occurs due to weakened immunity, contact lens wear, or eye injuries. Prompt diagnosis and new antifungal treatments improve outcomes for this rare condition.

Related Experiment Videos

Last Updated: Jun 2, 2026

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients
05:26

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients

Published on: March 1, 2024

Area of Science:

  • Ophthalmology
  • Mycology
  • Infectious Diseases

Context:

  • Fungal keratitis (keratomycosis) is a severe, albeit rare, cause of infectious keratitis.
  • Incidence is linked to factors like steroid/immunosuppressive therapy, contact lens wear, and ocular surface diseases.
  • Plant-related eye injuries are also a significant risk factor for fungal invasion.

Purpose:

  • To review the epidemiology, risk factors, and management of fungal keratitis.
  • To highlight the challenges in diagnosis and prognosis.
  • To discuss the impact of new antimycotic treatments.

Summary:

  • Fungal keratitis presents a poor prognosis due to fungal virulence, compromised host defenses, and diagnostic delays.
  • Despite challenges, advancements in antimycotic therapies are enhancing patient management and improving prognoses.
  • Early detection and appropriate treatment are crucial for managing this sight-threatening infection.

Impact:

  • Improved understanding of fungal keratitis risk factors and pathogenesis.
  • Highlights the importance of timely diagnosis and intervention.
  • Demonstrates the positive impact of novel antifungal treatments on clinical outcomes.